Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics
Sign Up to like & getrecommendations! Published in 2017 at "Therapeutic Advances in Cardiovascular Disease"
DOI: 10.1177/1753944717718718
Abstract: Background: Clopidogrel is by far the most prescribed platelet adenosine diphosphate (ADP) antagonist in Puerto Rico despite the advent of newer agents (prasugrel and ticagrelor). Given the paucity of data on clopidogrel responsiveness in Hispanics,… read more here.
Keywords: clinical determinants; puerto rican; platelet reactivity; patients clopidogrel ... See more keywords
The impact of smoking status on clopidogrel responsiveness in patients with coronary artery disease who undergo percutaneous coronary intervention
Sign Up to like & getrecommendations! Published in 2023 at "F1000Research"
DOI: 10.12688/f1000research.131820.1
Abstract: Background: Previous studies have pointed out the disproportionate action of clopidogrel in inhibiting platelet aggregation due to smoking more than ten cigarettes per a day. This study was designed to examine whether smoking enhances clopidogrel… read more here.
Keywords: clopidogrel responsiveness; clopidogrel; responsiveness patients; group ... See more keywords